|
Volumn 11, Issue 8 Suppl 8, 1997, Pages 37-41
|
Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
DRUG DERIVATIVE;
PACLITAXEL;
TAXOID;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
BACTERIAL INFECTION;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
FEMALE;
FEVER;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METASTASIS;
MIDDLE AGED;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
REMISSION;
ADULT;
AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BACTERIAL INFECTIONS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS, PHASE III;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
FEVER;
HEART FAILURE, CONGESTIVE;
HUMANS;
INFUSIONS, INTRAVENOUS;
INJECTIONS, INTRAVENOUS;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEUTROPENIA;
PACLITAXEL;
REMISSION INDUCTION;
TAXOIDS;
|
EID: 0031204255
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (17)
|
References (0)
|